TickrTrends LGND fair value analysis

Ligand to Participate in September Investor Conferences

manilatimes.net · 2026-08-26

JUPITER, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced its senior management team will participate in the following upcoming investor conferences:

Read the full story at manilatimes.net →

Is LGND undervalued? See TickrTrends' fair value analysis →